|
Volumn 32, Issue 4, 1996, Pages 667-670
|
Clinical trials -anxiety disorders venlafaxine for panic disorder: Results from a double-blind, placebo-controlled study
|
Author keywords
Agoraphobia; Panic disorder; Venlafaxine
|
Indexed keywords
PLACEBO;
VENLAFAXINE;
ADULT;
AGORAPHOBIA;
ANXIETY NEUROSIS;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DIAGNOSTIC ACCURACY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
MALE;
OBSESSION;
OUTPATIENT CARE;
PRIORITY JOURNAL;
PSYCHOSIS;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
SUBSTANCE ABUSE;
TREATMENT PLANNING;
ADULT;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
CYCLOHEXANOLS;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PANIC DISORDER;
|
EID: 0030480395
PISSN: 00485764
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (96)
|
References (1)
|